Estimation paramétrique par intervalle de confiance, Statistique, pp.135-166, 2010. ,
Estimation paramétrique par intervalle de confiance, Statistique, pp.135-166, 2010. ,
Incidence of Uveal Melanoma in Europe, Ophthalmology, vol.114, issue.12, pp.2309-2315.e2, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00492638
Incidence of noncutaneous melanomas in the U.S., Cancer, vol.103, issue.5, pp.1000-1007, 2005. ,
Metastatic disease from uveal melanoma: treatment options and future prospects, British Journal of Ophthalmology, vol.101, issue.1, pp.38-44, 2016. ,
The National Cancer Data Base report on cutaneous and noncutaneous melanoma, Cancer, vol.83, issue.8, pp.1664-1678, 1998. ,
Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma, British Journal of Ophthalmology, vol.98, issue.6, pp.769-774, 2013. ,
Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options, Cancer, vol.120, issue.6, pp.781-789, 2013. ,
Therapeutic Options in Metastatic Uveal Melanoma, Current Concepts in Uveal Melanoma, vol.49, pp.166-181, 2011. ,
Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma, Investigative Opthalmology & Visual Science, vol.44, issue.11, p.4651, 2003. ,
Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie, European Journal of Surgical Oncology (EJSO), vol.35, issue.11, pp.1192-1197, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00556287
Prospective study of surveillance testing for metastasis in 100 high-risk uveal melanoma patients, Journal Français d'Ophtalmologie, vol.38, issue.6, pp.526-534, 2015. ,
Diffusion-weighted MRI for uveal melanoma liver metastasis detection, European Radiology, vol.25, issue.8, pp.2263-2273, 2015. ,
Diffusion-weighted MRI for uveal melanoma liver metastasis detection, European Radiology, vol.25, issue.8, pp.2263-2273, 2015. ,
Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging, European Radiology, vol.21, issue.4, pp.832-840, 2010. ,
A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases, European Radiology, vol.26, issue.12, pp.4595-4615, 2016. ,
Hypointensity on Diffusion-Weighted MRI of the Brain Related to T2 Shortening and Susceptibility Effects, American Journal of Roentgenology, vol.181, issue.6, pp.1705-1709, 2003. ,
Uveal melanoma: epidemiology, etiology, and treatment of primary disease, Clinical Ophthalmology, vol.Volume 11, pp.279-289, 2017. ,
Uveal melanoma, Melanoma Research, vol.9, issue.6, pp.575-582, 1999. ,
Uveal melanoma: relatively rare but deadly cancer, Eye, vol.31, issue.2, pp.241-257, 2016. ,
Imaging of ocular melanoma metastasis, The British Journal of Radiology, vol.89, issue.1065, p.20160092, 2016. ,
Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death, Cancer Research, vol.64, issue.20, pp.7205-7209, 2004. ,
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis, The Oncologist, vol.21, issue.7, pp.848-854, 2016. ,
Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis, JAMA Ophthalmology, vol.131, issue.8, p.993, 2013. ,
The Association Between Host Susceptibility Factors and Uveal Melanoma, Archives of Ophthalmology, vol.124, issue.1, p.54, 2006. ,
Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma, Ophthalmology, vol.119, issue.8, pp.1596-1603, 2012. ,
Faculty Opinions recommendation of Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma., Ophthalmology. août, vol.119, issue.8, pp.1596-603, 2012. ,
Intermittent and Chronic Ultraviolet Light Exposure and Uveal Melanoma, Ophthalmology, vol.112, issue.9, pp.1599-1607, 2005. ,
Oncogenic signaling in uveal melanoma, Pigment Cell & Melanoma Research, vol.31, issue.6, pp.661-672, 2018. ,
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, vol.457, issue.7229, pp.599-602, 2008. ,
Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients, Arch Ophthalmol Chic Ill, vol.119, issue.8, pp.989-98, 1960. ,
Fine-needle aspiration biopsy in the management of choroidal melanoma, Current Opinion in Ophthalmology, vol.24, issue.3, pp.262-266, 2013. ,
Multi-Year Follow-up of Fine-Needle Aspiration Biopsy in Choroidal Melanoma, Ophthalmology, vol.119, issue.3, pp.606-610, 2012. ,
Modifications of Callender's Classification of Uveal Melanoma at the Armed Forces Institute of Pathology, American Journal of Ophthalmology, vol.195, pp.lvi-lx, 2018. ,
Uveal melanoma: Estimating prognosis, Indian Journal of Ophthalmology, vol.63, issue.2, p.93, 2015. ,
International Validation of the American Joint Committee on Cancer?s 7th Edition Classification of Uveal Melanoma, JAMA Ophthalmology, vol.133, issue.4, p.376, 2015. ,
American Joint Committee on Cancer Classification of Posterior Uveal Melanoma (Tumor Size Category) Predicts Prognosis in 7731 Patients, Ophthalmology, vol.120, issue.10, pp.2066-2071, 2013. ,
CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES, Retina, vol.32, issue.7, pp.1363-1372, 2012. ,
Gender Differences in Clinical Presentation and Prognosis of Uveal Melanoma, Investigative Opthalmology & Visual Science, vol.54, issue.1, p.652, 2013. ,
Genomic Profile of 320 Uveal Melanoma Cases: Chromosome 8p-Loss and Metastatic Outcome, Investigative Opthalmology & Visual Science, vol.54, issue.8, p.5721, 2013. ,
A Prognostic Test to Predict the Risk of Metastasis in Uveal Melanoma Based on a 15-Gene Expression Profile, Methods in Molecular Biology, vol.1102, pp.427-440, 2013. ,
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas, Science, vol.330, issue.6009, pp.1410-1413, 2010. ,
SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma, Cancer Discovery, vol.3, issue.10, pp.1122-1129, 2013. ,
Association of Uveal Melanoma Metastatic Rate With Stochastic Mutation Rate and Type of Mutation, JAMA Ophthalmology, vol.136, issue.10, p.1115, 2018. ,
GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi, British Journal of Cancer, vol.117, issue.6, pp.884-887, 2017. ,
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma, Cancer Cell, vol.33, issue.1, p.151, 2018. ,
Presentation, Treatment, and Prognosis of Secondary Melanoma within the Orbit, Frontiers in Oncology, vol.7, p.125, 2017. ,
Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma, Archives of Ophthalmology, vol.123, issue.12, p.1639, 2005. ,
Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma, Archives of Ophthalmology, vol.123, issue.12, p.1639, 2005. ,
Adjuvant Therapy of Uveal Melanoma: Current Status, Ocular Oncology and Pathology, vol.1, issue.1, pp.54-62, 2015. ,
Long-Term Survivors with Metastatic Uveal Melanoma, The Open Ophthalmology Journal, vol.6, issue.1, pp.49-53, 2012. ,
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial, Annals of Oncology, vol.25, issue.3, pp.742-746, 2014. ,
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial, Annals of Oncology, vol.25, issue.3, pp.742-746, 2014. ,
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma, Annals of Oncology, vol.24, issue.11, pp.2911-2915, 2013. ,
Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies, Current Oncology Reports, vol.19, issue.7, p.45, 2017. ,
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial, The Lancet Oncology, vol.16, issue.4, pp.375-384, 2015. ,
The use of pembrolizumab for the treatment of metastatic uveal melanoma, Melanoma Research, vol.26, issue.3, pp.300-303, 2016. ,
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies, Cancer, vol.122, issue.21, pp.3344-3353, 2016. ,
Prolonged survival after complete resection of metastases from intraocular melanoma, Cancer, vol.100, issue.1, pp.122-129, 2003. ,
Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma, European Journal of Surgical Oncology (EJSO), vol.42, issue.5, pp.706-712, 2016. ,
Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma, European Journal of Surgical Oncology (EJSO), vol.42, issue.5, pp.706-712, 2016. ,
, European Journal of Surgical Oncology, vol.0, issue.0, pp.1-10, 2002.
Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma, JAMA Ophthalmology, vol.134, issue.2, p.174, 2016. ,
Screening for metastatic malignant melanoma of the uvea revisited, Cancer, vol.85, issue.5, pp.1151-1159, 1999. ,
Surveillance Testing for Metastasis From Primary Uveal Melanoma and Effect on Patient Survival, American Journal of Ophthalmology, vol.152, issue.1, pp.5-9.e1, 2011. ,
Limited detection of small (? 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection, PLOS ONE, vol.12, issue.12, p.e0189797, 2017. ,
Hepatic Abnormalities Identified on Abdominal Computed Tomography at Diagnosis of Uveal Melanoma, Archives of Ophthalmology, vol.128, issue.3, p.319, 2010. ,
Characterization of Computed Tomography Scan Abnormalities in Patients With Biopsy-Proven Hepatic Metastases From Uveal Melanoma, Archives of Ophthalmology, vol.129, issue.12, p.1576, 2011. ,
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions, European Radiology, vol.18, issue.3, pp.457-467, 2007. ,
Detection of metastatic disease in patients with uveal melanoma using positron emission tomography, European Journal of Surgical Oncology (EJSO), vol.32, issue.7, pp.780-784, 2006. ,
Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET), European Journal of Surgical Oncology (EJSO), vol.36, issue.2, pp.189-194, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00557766
Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.36, issue.11, pp.1774-1782, 2009. ,
Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions, World Journal of Radiology, vol.1, issue.1, p.72, 2009. ,
Diagnostic Imaging of Colorectal Liver Metastases with CT, MR Imaging, FDG PET, and/or FDG PET/CT: A Meta-Analysis of Prospective Studies Including Patients Who Have Not Previously Undergone Treatment, Radiology, vol.257, issue.3, pp.674-684, 2010. ,
Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases, Neuroendocrinology, vol.106, issue.1, pp.74-88, 2017. ,
MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients, British Journal of Ophthalmology, vol.97, issue.2, pp.159-163, 2012. ,
Additional benefit of computed diffusion-weighted imaging for detection of hepatic metastases at 1.5T, Clinical Imaging, vol.40, issue.3, pp.481-485, 2016. ,
Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shotT2weighted turbo spin echo techniques, The British Journal of Radiology, vol.80, issue.955, pp.524-531, 2007. ,
Detection and classification of focal liver lesions in patients with colorectal cancer: Retrospective comparison of diffusion-weighted MR imaging and multi-slice CT, European Journal of Radiology, vol.81, issue.4, pp.683-691, 2012. ,
Diagnosis of Hepatic Metastasis: Comparison of Respiration-Triggered Diffusion-Weighted Echo-Planar MRI and Five T2-Weighted Turbo Spin-Echo Sequences, American Journal of Roentgenology, vol.191, issue.5, pp.1421-1429, 2008. ,
High Sensitivity of Diffusion-weighted MR Imaging for the Detection of Liver Metastases from Neuroendocrine Tumors: Comparison with T2-weighted and Dynamic Gadolinium-enhanced MR Imaging, Radiology, vol.268, issue.2, pp.390-399, 2013. ,
Is diffusion-weighted MRI sufficient for follow-up of neuroendocrine tumour liver metastases?, Clinical Radiology, vol.71, issue.9, pp.863-868, 2016. ,
Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates, World Journal of Hepatology, vol.9, issue.26, p.1081, 2017. ,
Diffusion-weighted MR Imaging of the Liver, Radiology, vol.254, issue.1, pp.47-66, 2010. ,
Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging, Radiology, vol.246, issue.3, pp.812-822, 2008. ,
Evaluation of Liver Diffusion Isotropy and Characterization of Focal Hepatic Lesions with Two Single-Shot Echo-planar MR Imaging Sequences: Prospective Study in 66 Patients, Radiology, vol.226, issue.1, pp.71-78, 2003. ,
Artifacts and pitfalls in diffusion MRI, J Magn Reson Imaging JMRI. sept, vol.24, issue.3, pp.478-88, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00349658
Improved Detection of Focal Liver Lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid?enhanced MR Images with Intraoperative Findings, Radiology, vol.230, issue.1, pp.266-275, 2004. ,
Randomized multicentre trial of gadoxetic acid-enhanced MRIversusconventional MRI or CT in the staging of colorectal cancer liver metastases, British Journal of Surgery, vol.101, issue.8, pp.1035-1035, 2014. ,
Randomized multicentre trial of gadoxetic acid-enhanced MRIversusconventional MRI or CT in the staging of colorectal cancer liver metastases (Br J Surg2014; 101: 613-621), British Journal of Surgery, vol.101, issue.6, pp.622-622, 2014. ,
MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-Specific Contrast Agent Gadoxetic Acid, Korean Journal of Radiology, vol.14, issue.6, p.894, 2013. ,
Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI, World Journal of Hepatology, vol.6, issue.7, p.477, 2014. ,
Gadoxetic Acid?Enhanced Hepatobiliary Phase MRI and High-b-Value Diffusion-Weighted Imaging to Distinguish Well-Differentiated Hepatocellular Carcinomas From Benign Nodules in Patients With Chronic Liver Disease, American Journal of Roentgenology, vol.197, issue.5, pp.W868-W875, 2011. ,
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients, European Radiology, vol.22, issue.1, pp.171-180, 2011. ,
Liver Perfusion Modifies Gd-DTPA and Gd-BOPTA Hepatocyte Concentrations Through Transfer Clearances Across Sinusoidal Membranes, European Journal of Drug Metabolism and Pharmacokinetics, vol.42, issue.4, pp.657-667, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01917871
Diagnosis of colorectal hepatic metastases: Comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI, Journal of Magnetic Resonance Imaging, vol.34, issue.2, pp.326-335, 2011. ,
Detection of Pancreatic Carcinoma and Liver Metastases with Gadoxetic Acid?enhanced MR Imaging: Comparison with Contrast-enhanced Multi?Detector Row CT, Radiology, vol.260, issue.2, pp.446-453, 2011. ,
Magnetic Resonance Imaging for Colorectal Cancer Metastasis to the Liver: Comparative Effectiveness Research for the Choice of Contrast Agents, Cancer Research and Treatment, vol.50, issue.1, pp.60-70, 2018. ,
Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases, The British Journal of Radiology, vol.85, issue.1015, pp.980-989, 2012. ,
Role of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in the Preoperative Evaluation of Small Hepatic Lesions in Patients with Colorectal Cancer, World Journal of Surgery, vol.39, issue.5, pp.1161-1166, 2015. ,
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination, European Radiology, vol.18, issue.5, pp.903-910, 2008. ,
Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases, Annals of Surgical Oncology, vol.23, issue.12, pp.3991-3998, 2016. ,
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents, European Radiology, vol.26, issue.4, pp.921-931, 2015. ,
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging, European Radiology, vol.26, issue.3, pp.674-682, 2015. ,
Diffusion-weighted MRI and optimal b-value for characterization of liver lesions, Acta Radiologica, vol.55, issue.5, pp.532-542, 2014. ,
Quantification of melanin and iron content in uveal malignant melanomas and correlation with magnetic resonance image., British Journal of Ophthalmology, vol.77, issue.5, pp.297-301, 1993. ,
Acute Cerebral Infarction: Quantification of Spin-Density and T2 Shine-through Phenomena on Diffusion-weighted MR Images, Radiology, vol.212, issue.2, pp.333-339, 1999. ,
Identification of an Immunogenic Subset of Metastatic Uveal Melanoma, Clinical Cancer Research, vol.22, issue.9, pp.2237-2249, 2015. ,
A method for dynamic subtraction MR imaging of the liver, BMC Medical Imaging, vol.6, issue.1, p.5, 2006. ,